Search for: "MYLAN INC."
Results 101 - 120
of 674
Sort by Relevance
|
Sort by Date
4 Sep 2019, 7:17 am
FASHION. 5842251 INDIANA DRUG ENFORCEMENT ASSOCIATION IDEA 5846432 PREVENTIA 5842222 MIER PRODUCTS, INC. 5847208 COMMERCIAL DASHBOARD 5846406 TRIUMPH 5846302 THE SIMPLE 9 5841996 ACACIA 5845875 ACTIVEARTH 5840833 BLUEHIVE 5837486 INTELLIGLOBE 5840762 K KOCOLENE INVESTMENTS 5837402 FATBOY 5837397 SPECOIL 5840623 PAI 5841364 PLAYER ATHLETIC INDEX 5841358 BAND ACADEMY 5837297 RAGGS 5840500 FOUNDATION FOR FRATERNAL EXCELLENCE 5840479 VINDICATE 5840463 COMMITTED TO THE JOURNEY OF MAKING LIVES… [read post]
19 Aug 2019, 11:39 am
Mylan Laboratories Ltd., 757 Fed. [read post]
24 Jun 2019, 10:00 pm
Mylan Pharmaceuticals, Inc., 896 F.3d 1322 (Fed. [read post]
18 Jun 2019, 11:31 am
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
16 Jun 2019, 9:30 pm
Mylan Pharmaceuticals Inc.), held that State sovereign immunity does not preclude institution of inter partes review proceedings before the Patent Trial and Appeal Board (PTAB) of the U.S. [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d... [read post]
14 Jun 2019, 12:24 pm
Mylan Pharmaceuticals Inc., 896 F.3d 1322 (Fed. [read post]
14 May 2019, 11:24 am
Mylan Labs., Inc., 464 F.3d 1286,1289 (Fed. [read post]
14 May 2019, 11:12 am
See Housey Pharm., Inc. v. [read post]
8 May 2019, 7:14 am
” It’s not enough to put an unapproved drug on the market with a FDA-ish package insert, according to Mylan Labs., Inc. v. [read post]
17 Mar 2019, 3:11 am
PatentsThe Kluwer Patent Blog reports on the results of the EPO's online user consultation concerning a procedural option for postponing examination of a European patent application and on the decision of the Danish Maritime and Commercial Court to grant an injunction against Mylan AB's sale of the product Tadalafil »Mylan« containing 5 mg Tadalafil in Denmark. [read post]
13 Mar 2019, 9:10 am
Mylan Pharmaceuticals, Inc., et al., No. 18-899 (May tribal sovereign immunity may be asserted to bar IPR review of patents owned by the tribe?) [read post]
11 Mar 2019, 7:08 pm
The Momenta Appeal At the time of its 2015 petition for inter partes review, Momenta was working with Mylan to develop a biosimilar counterpart to Orencia®, the branded biologic drug whose active ingredient was covered by the BMS patent. [read post]
4 Mar 2019, 1:14 pm
Mylan, Inc., 853 F.3d 1296, 1302 n.1(Fed. [read post]
28 Feb 2019, 8:47 pm
Mylan Laboratories... [read post]
21 Feb 2019, 9:29 pm
Mylan Pharmaceuticals Inc., No. 2018-2097 ("Valeant II"), Salix moves to disqualify in Salix Pharmaceuticals, Inc. v. [read post]
21 Feb 2019, 12:11 pm
Mylan Pharma., Inc., available here. [read post]
21 Feb 2019, 8:45 am
Mylan Pharmaceuticals Inc., No. 2018-2097 (“Valeant II”), Salix moves todisqualify in Salix Pharmaceuticals, Inc. v. [read post]
14 Feb 2019, 9:50 pm
RE38,551 challenged in inter partes review were not unpatentable for obviousness, in Mylan Pharmaceuticals Inc. v. [read post]
14 Feb 2019, 7:05 am
Mylan Pharmaceuticals Inc. 18-899 Issue: Whether inter partes review before the Patent Trial and Appeal Board is the type of proceeding in which tribal sovereign immunity may be asserted. [read post]
